Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by ruth on October 30, 2007
Foolowing the results of the a study on the efficacy and safety of Trasylol, a drug used to prevent excessive bleeding during heart bypass surgery, the FDA issued a warning that the drug also raises the risk of death in comparison to other drugs. Trasylol, also known as aprotinin, works by blocking enzymes that dissolve blood clots
Source: Fox News
Bayer said it believes Trasylol remains a safe and effective treatment option, but that the company would work with the FDA and regulators in other countries to re-evaluate the drug's risks and benefits and determine where any label changes are needed.
The FDA said such changes, as well as other, unspecified regulatory actions, may result.
Source: Fox News
Permalink: Heart Drug Trasylol May Boost Risk of Death
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/99501
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Heart Drug Trasylol May Boost Risk of Death:
|
Rating: 9.00 out of 1 vote(s) cast.
|
Response from:
Tech|noob
These shirts are simply amazing. You see those hearts? They will glow, but only when one T-shirt is close
Response from:
Trusted.MD Network
Pioneering heart surgeon, Michael E. DeBakey died on Saturday (July 11) in Methodist Hospital Houston at the age of 99.
Who is Dr. Michael E. DeBakey?
father of modern cardiovascular surgery
invented scores of medical procedures and instruments
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
